Article Text

Download PDFPDF
Randomised controlled trial
The addition of nebulised magnesium to the standard asthma therapy for children with severe symptoms results in small improvements in asthma severity scores
  1. Joseph J Zorc
  1. Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania, USA
  1. Correspondence to : Dr Joseph J Zorc, CTRB 9004, The Children's Hospital of Philadelphia, 34th and Civic Center Blvd, University of Pennsylvania, Philadelphia, PA 19104, USA; zorc{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on: OpenUrlWeb of Science


The prior research has found that magnesium sulfate given intravenously acts as a bronchodilator and improves airway obstruction in status asthmaticus.1 The intravenous route requires substantial resources for administration and close monitoring due to concerns for adverse effects, such as hypotension. Several studies have suggested that nebulised magnesium may also have benefits.2 If the efficacy was demonstrated for nebulised magnesium, it could be added to bronchodilators in the standard asthma treatment protocols, providing an important advance in the treatment …

View Full Text


  • Competing interests None.